Bristol-Myers Squibb Co (BMY)
48.64
+0.34
(+0.70%)
USD |
NYSE |
Apr 19, 13:08
Bristol-Myers Squibb Free Cash Flow (Quarterly): 3.922B for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.922B |
| September 30, 2023 | 4.409B |
| June 30, 2023 | 1.628B |
| March 31, 2023 | 2.692B |
| December 31, 2022 | 2.96B |
| September 30, 2022 | 3.44B |
| June 30, 2022 | 1.989B |
| March 31, 2022 | 3.559B |
| December 31, 2021 | 3.737B |
| September 30, 2021 | 4.996B |
| June 30, 2021 | 2.85B |
| March 31, 2021 | 3.651B |
| December 31, 2020 | 3.072B |
| September 30, 2020 | 2.114B |
| June 30, 2020 | 4.362B |
| March 31, 2020 | 3.751B |
| December 31, 2019 | 1.93B |
| September 30, 2019 | 2.366B |
| June 30, 2019 | 1.892B |
| March 31, 2019 | 1.186B |
| December 31, 2018 | 3.265B |
| September 30, 2018 | 1.055B |
| June 30, 2018 | 859.00M |
| March 31, 2018 | 936.00M |
| December 31, 2017 | 863.00M |
| Date | Value |
|---|---|
| September 30, 2017 | 1.451B |
| June 30, 2017 | 1.336B |
| March 31, 2017 | 570.00M |
| December 31, 2016 | 1.072B |
| September 30, 2016 | 1.063B |
| June 30, 2016 | 178.00M |
| March 31, 2016 | -470.00M |
| December 31, 2015 | 599.00M |
| September 30, 2015 | 290.00M |
| June 30, 2015 | -94.00M |
| March 31, 2015 | 490.00M |
| December 31, 2014 | 381.00M |
| September 30, 2014 | 796.00M |
| June 30, 2014 | 946.00M |
| March 31, 2014 | 499.00M |
| December 31, 2013 | 1.21B |
| September 30, 2013 | 929.00M |
| June 30, 2013 | 1.412B |
| March 31, 2013 | -543.00M |
| December 31, 2012 | 661.00M |
| September 30, 2012 | 4.447B |
| June 30, 2012 | 1.021B |
| March 31, 2012 | 264.00M |
| December 31, 2011 | 1.434B |
| September 30, 2011 | 1.614B |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
1.628B
Minimum
Jun 2023
4.996B
Maximum
Sep 2021
3.122B
Average
3.072B
Median
Dec 2020
Free Cash Flow (Quarterly) Benchmarks
| Amgen Inc | 289.00M |
| Gilead Sciences Inc | 1.954B |
| Johnson & Johnson | 5.804B |
| Karuna Therapeutics Inc (DELISTED) | -111.86M |
| 2seventy bio Inc | -64.67M |